March 26 (Reuters) - Whitehawk Therapeutics Inc WHWK.O:
WHITEHAWK THERAPEUTICS COMPLETES STRATEGIC TRANSFORMATION WITH SUCCESSFUL CLOSING OF SALE OF AADI SUBSIDIARY TO KAKEN PHARMACEUTICALS
Source text: ID:nPn37GL3Na
Further company coverage: WHWK.O
((Reuters.Briefs@thomsonreuters.com;))